Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
. 2013 Mar;34(3):603-8.
doi: 10.3174/ajnr.A3230. Epub 2012 Aug 9.

Evaluation of an intravenous-endovascular strategy in patients with acute proximal middle cerebral artery occlusion

Affiliations
Controlled Clinical Trial

Evaluation of an intravenous-endovascular strategy in patients with acute proximal middle cerebral artery occlusion

J-F Vendrell et al. AJNR Am J Neuroradiol. 2013 Mar.

Abstract

Background and purpose: IVT administered in acute ischemic stroke provides low recanalization rates in proximal intracranial occlusions, with consequently poor clinical outcome. The safety and efficacy of an IES by using mechanical thrombectomy after IVT failure were assessed in acute MCA occlusions.

Materials and methods: Patients presenting with acute MCA occlusion within 4.5 hours with an NIHSS score between 8 and 25 and a DWI ASPECTS of >5 were eligible. From September 2009 to September 2010, mechanical thrombectomy by using the Solitaire FR device was systematically performed if no clinical improvement was observed 1 hour after the initiation of IVT (IES group). Results in terms of clinical outcome were compared with those from an IVT series from January 2007 to August 2009 (IVT group).

Results: Alteplase was administered in 123 patients with proximal intracranial occlusion. Fifty-six had a confirmed MCA occlusion: 32 were included in the IVT group; and 24, in the IES group. At 24 hours, the median NIHSS improvement was 8.5 points in the IES group (25%-75% CI, 1.5-13) and 3 points in the IVT group (25%-75% CI, 1-5) (P = .001). At 3 months, 17/22 (77%) patients from the IES group and 15/30 (50%) from the IVT group had an mRS score of ≤2. After adjustment for confounding variables, IES was strongly associated with favorable clinical outcome (77% versus 50%; adjusted odds ratio = 11.9; 95% CI, 1.6-89.1; P < .02). No symptomatic intracranial hemorrhage was observed.

Conclusions: IES by using systematic mechanical thrombectomy after IVT failure safely improves the clinical outcome at 3 months and could represent an interesting alternative in the management of patients with acute MCA occlusion.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Flowchart of patients and outcome at 3 months.

References

    1. Bluhmki E, Chamorro A, Machnig T, et al. . Stroke treatment with alteplase given 3.0–4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomized controlled trial. Lancet Neurol 2009;8:1095–102 - PubMed
    1. del Zoppo GJ, Poeck K, Pessin MS, et al. . Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78–86 - PubMed
    1. Bhatia R, Hill MD, Shobha N, et al. . Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 2010;41:2254–58 - PubMed
    1. Furlan A, Higashida R, Wechsler L, et al. . Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial—Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11 - PubMed
    1. Mattle HP, Arnold M, Georgiadis D, et al. . Comparison of intra-arterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 2008;39:379–83 - PubMed

Publication types

Substances

LinkOut - more resources